Tilray Slides on Loss, While Analysts Focus on Revenue Beat

Tilray Inc. fell 12% in pre-market procuring and selling after the pot firm reported a great wider-than-anticipated Ebitda loss, offsetting earnings that beat analyst estimates.
Read More

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button